We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity.AuthorsZahiragic, L; Schliemann, C; Bieker, R; Thoennissen, N H; Burow, K; Kramer, C; Zühlsdorf, M; Berdel, W E; Mesters, R MPublicationLeukemia, 2007, Vol 21, Issue 6, p1310ISSN0887-6924Publication typeResearchDOI10.1038/sj.leu.2404632